Radiolabelling of the human 5-HT2A receptor with an agonist, a partial agonist and an antagonist: Effects on apparent agonist affinities
- 1 January 1996
- journal article
- Published by Elsevier BV in Biochemical Pharmacology
- Vol. 51 (1), 71-76
- https://doi.org/10.1016/0006-2952(95)02122-1
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Molecular biology of 5-HT receptorsNeuropharmacology, 1994
- A proposed new nomenclature for 5-HT receptorsTrends in Pharmacological Sciences, 1993
- Genomic organization, coding sequence and functional expression of human 5-HT2 and 5-HT1A receptor genesEuropean Journal of Pharmacology: Molecular Pharmacology, 1992
- Differentiation of 5-hydroxytryptamine2 receptor subtypes using 125I-R- (-)2,5-dimethoxy-4-iodo-phenylisopropylamine and 3H-ketanserinJournal of Neuroscience, 1989
- Regulation of serotonin-stimulated phosphoinositide hydrolysis: relation to the serotonin 5-HT-2 binding siteJournal of Neuroscience, 1986
- Molecular pharmacology of 5-HT1 and 5-HT2 recognition sites in rat and pig brain membranes: Radioligand binding studies with [3H]5-HT, [3H]8-OH-DPAT, (−)[125I]iodocyanopindolol, [3H]mesulergine and [3H]KetanserinEuropean Journal of Pharmacology, 1985
- [3H]DOB: A specific agonist radioligand for 5-HT2 serotonin receptorsEuropean Journal of Pharmacology, 1985
- Selective 5ht-2 antagonists inhibit serotonin stimulated phosphatidylinositol metabolism in cerebral cortexNeuropharmacology, 1984
- LIGAND: A versatile computerized approach for characterization of ligand-binding systemsAnalytical Biochemistry, 1980
- TWO KINDS OF TRYPTAMINE RECEPTORBritish Journal of Pharmacology and Chemotherapy, 1957